ASKA Pharmaceutical Holdings Co.,Ltd. (4886.T) JPX

Currency In JPY

AD

ASKA Pharmaceutical Holdings Co.,Ltd.

Address

5-1, Shibaura 2-Chome

Tokyo, TY 108-8532

Japan

Phone

81 3 5484 8845

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

Employees

1611

First IPO Date

April 01, 2021

Key Executives

NameTitlePayYear Born
Atsushi MaruoSenior Managing Director & Representative Director01959
Takashi YamaguchiRepresentative Director & Chairman of the Board01952
Fumiyoshi YamaguchiManaging Executive Officer and Director01986
Maiko MoriManaging Executive Officer and Director01964
Kiyohiko TamuraExecutive Corporate Officer & Director of Group Business Management Division0N/A
Tomoyuki HatakeyamaDirector of Finance & Accounting Dept., Group Bus. Mgmt Div. and Manager of Accounting Section0N/A
Sohta YamaguchiPresident & Representative Director01983
AD

Description

ASKA Pharmaceutical Holdings Co.,Ltd. is a Japanese enterprise that operates through its subsidiaries in three primary areas: pharmaceuticals, animal healthcare, and hormone testing services. The company's pharmaceutical division is dedicated to the research, development, production, and commercialization of medications, with a specific focus on endocrinology, obstetrics and gynecology, and urology. Within its animal health segment, ASKA manufactures, sells, imports, and exports a broad spectrum of veterinary products, such as medicines, medical equipment, animal feed and supplements, laboratory reagents, agricultural chemicals, industrial chemicals, hygiene products, and food items along with their raw materials. Beyond these activities, the company also performs clinical and biological testing and offers medical devices. Founded in 1920, ASKA Pharmaceutical Holdings Co.,Ltd. is headquartered in Tokyo, Japan.

AD